METHODS OF TREATING MULTIPLE MYELOMA WITH IMMUNOREGULATORY COMPOUNDS IN COMBINATION WITH ANTIBODIES
CY1125886T1Undetermined Publication Date: 2026-04-17CELGENE CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100139T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2014-08-22
- Filing Date
- 2023-03-14
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2043-03-14
Abstract
Methods of treating, preventing and / or managing multiple myeloma are disclosed. Specific methods include administering an immunomodulatory compound, e.g., lenalidomide or pomalidomide with an anti-CS1 antibody, e.g., elotuzumab, to patients who have undergone autologous stem cell transplantation.
Need to check novelty before this filing date? Find Prior Art